Ramonas L M, Erickson L C, McManus M E
Mol Pharmacol. 1982 Jul;22(1):175-81.
The effect of misonidazole on the cytotoxicity of 4-S-(propionic acid)-sulfidocyclophosphamide (C-2) was assessed by measuring the colony-forming ability of mouse L1210 leukemia cells. C-2 under physiological conditions spontaneously hydrolyzes to 4-hydroxycyclophosphamide. Misonidazole alone at a concentration of 2.5 mM was only slightly toxic to hypoxic L1210 cells and allowed a greater than 90% survival following a 2-hr exposure. Combined treatment of C-2 and 2.5 mM misonidazole resulted in a cell kill that was greater than the additive toxicities of C-2 and misonidazole. The synergistic toxicity of the C-2 and misonidazole (2.5 mM) combination increased with increasing C-2 concentration, and at 0.01 survival the dose-modification ratio of C-2 alone versus the combination was approximately 1.5. Similarly, when the concentration of C-2 was held constant (10 microM) and the concentration of misonidazole varied from 2.5 to 25 mM, a cell kill greater than the additive toxicities of misonidazole and C-2 alone was observed. The kinetic patterns of formation and removal of DNA interstrand cross-links following a 2-hr treatment of 10 microM C-2 or 10 microM C-2 plus 2.5 mM misonidazole were similar. However, with the exception of the 0-hr time point, cells treated with the C-2 plus misonidazole combination showed consistently greater cross-linking of DNA than did cells treated with C-2 alone. The interstrand cross-link ratio closely correlated with the cytotoxic dose-modification ratio of the combination compared with C-2 alone.
通过测量小鼠L1210白血病细胞的集落形成能力,评估了米索硝唑对4-S-(丙酸)-硫化环磷酰胺(C-2)细胞毒性的影响。C-2在生理条件下会自发水解为4-羟基环磷酰胺。浓度为2.5 mM的米索硝唑单独使用时,对缺氧的L1210细胞仅有轻微毒性,暴露2小时后存活率大于90%。C-2与2.5 mM米索硝唑联合处理导致的细胞杀伤作用大于C-2和米索硝唑的相加毒性。C-2与米索硝唑(2.5 mM)联合使用时的协同毒性随C-2浓度增加而增强,在存活率为0.01时,单独使用C-2与联合用药的剂量修正比约为1.5。同样,当C-2浓度保持恒定(10 μM)且米索硝唑浓度从2.5 mM变化至25 mM时,观察到细胞杀伤作用大于米索硝唑和C-2单独使用时的相加毒性。用10 μM C-2或10 μM C-2加2.5 mM米索硝唑处理2小时后,DNA链间交联形成和去除的动力学模式相似。然而,除了0小时时间点外,用C-2加米索硝唑联合处理的细胞显示出的DNA交联始终比单独用C-2处理的细胞更强。与单独使用C-2相比,链间交联比与联合用药的细胞毒性剂量修正比密切相关。